<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T17:22:22Z</responseDate>
  <request identifier="oai:figshare.com:article/33813556" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33813556</identifier>
        <datestamp>2026-09-15T17:51:27Z</datestamp>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_62</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Clinical outcome definitions and observed event rates for ischemic and bleeding endpoints in the UAE development cohort and the external validation cohort. Composite outcomes were prespecified and applied uniformly across datasets to ensure consistency in model development and validation.&lt;/p&gt;</dc:title>
          <dc:creator>Hassa Iftikhar (24234732)</dc:creator>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Marine Biology</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>united arab emirates</dc:subject>
          <dc:subject>percutaneous coronary intervention</dc:subject>
          <dc:subject>guided strategies informed</dc:subject>
          <dc:subject>exploratory analyses suggested</dc:subject>
          <dc:subject>established scoring systems</dc:subject>
          <dc:subject>economic implications compared</dc:subject>
          <dc:subject>dual antiplatelet therapy</dc:subject>
          <dc:subject>406 patients ).</dc:subject>
          <dc:subject>decision curve analysis</dc:subject>
          <dc:subject>weighted lightgbm model</dc:subject>
          <dc:subject>conventional risk scores</dc:subject>
          <dc:subject>estimate economic results</dc:subject>
          <dc:subject>major bleeding events</dc:subject>
          <dc:subject>composite ischemic events</dc:subject>
          <dc:subject>bleeding risk prediction</dc:subject>
          <dc:subject>machine learning model</dc:subject>
          <dc:subject>machine learning</dc:subject>
          <dc:subject>bleeding events</dc:subject>
          <dc:subject>ischemic events</dc:subject>
          <dc:subject>bleeding risk</dc:subject>
          <dc:subject>predicting ischemic</dc:subject>
          <dc:subject>model may</dc:subject>
          <dc:subject>model discrimination</dc:subject>
          <dc:subject>hypothetical risk</dc:subject>
          <dc:subject>potential decision</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>support tool</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>mimiciv database</dc:subject>
          <dc:subject>may serve</dc:subject>
          <dc:subject>main outcomes</dc:subject>
          <dc:subject>internal validation</dc:subject>
          <dc:subject>externally validated</dc:subject>
          <dc:subject>externally validate</dc:subject>
          <dc:subject>external validation</dc:subject>
          <dc:subject>discrimination performance</dc:subject>
          <dc:subject>comprising 4</dc:subject>
          <dc:subject>clinical utility</dc:subject>
          <dc:subject>812 participants</dc:subject>
          <dc:description>&lt;p&gt;Clinical outcome definitions and observed event rates for ischemic and bleeding endpoints in the UAE development cohort and the external validation cohort. Composite outcomes were prespecified and applied uniformly across datasets to ensure consistency in model development and validation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T17:51:05Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0353066.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Clinical_outcome_definitions_and_observed_event_rates_for_ischemic_and_bleeding_endpoints_in_the_UAE_development_cohort_and_the_external_validation_cohort_Composite_outcomes_were_prespecified_and_applied_uniformly_across_datasets_to_ensu/33813556</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
